Peptide HPLC-UV Purity vs LC-MS TIC Purity

Why UV area is usually the release purity value

At 214 nm, many peptide-related impurities have responses broadly similar to the parent on a mass basis, making UV area a practical purity estimate. It is not universal. Deletion sequences, aromatic-residue changes, fluorophores, lipid linkers, and nonpeptide contaminants can respond differently. Water, salts, and counterions may be invisible.

At 280 nm, response depends heavily on Trp and Tyr. A peptide without those residues may be barely visible, while an aromatic impurity dominates. A COA should state detector wavelength, not simply “HPLC purity.”

Integration also defines the result. Solvent-front material, peaks below threshold, and a shoulder merged with the main peak all change reported percentage. Request the full chromatogram, blank, integration table, gradient, column, temperature, and sample load.

TIC area is not a purity assay by default

Electrospray response varies enormously between peptides. A basic impurity may ionize far more efficiently than a neutral parent. A hydrophobic lipidated species may adsorb, aggregate, or form broad charge/adduct envelopes. One mole of each does not produce equal TIC area.

TFA is a classic source of disagreement. It can improve peptide peak shape and retention selectivity in reverse-phase HPLC while suppressing positive-mode electrospray. A published UV/MS study observed roughly ninefold MS suppression under its TFA conditions compared with formic-acid conditions. Switching modifier changes both response and sometimes separation, so a TIC percentage from one method cannot be pasted onto a UV purity method from another.

TIC also contains background ions, mobile-phase clusters, contaminants, and coeluting species outside the peptide family. Extracted-ion chromatograms improve selectivity but still carry compound-specific response bias. A weakly ionizing impurity may disappear; a strongly ionizing trace may look disproportionately large.

A credible comparison should include:

• UV chromatogram at stated wavelength with complete integration;
• TIC and extracted-ion chromatograms from the same injection;
• raw spectra across parent and impurity peaks;
• mobile-phase additives, source settings, scan range, and charge handling;
• blank and carryover runs;
• impurity standards or enriched fractions where quantitative response matters.

Use each detector for the question it answers

Use LC-MS to establish whether a UV peak has the expected peptide mass, a deletion, oxidation, adduct, or unrelated background. Use UV area for routine related-substance quantitation when the method is selective and response assumptions are justified. Use calibrated MS when sensitivity or matrix selectivity is needed and authentic standards or qualified relative response factors are available.

Online UV-MS is powerful because retention aligns the two views. A UV peak without MS signal may be a nonionizing impurity, suppressed peptide, salt-related feature, or detector-path mismatch. An MS feature without UV signal may be too dilute for UV, exceptionally ionizable, or background contamination. Neither should be deleted merely because the other detector does not see it.

Acquisition rate matters. Too few MS scans across a narrow HPLC peak produce inaccurate TIC integration. Source saturation flattens a high parent signal, making impurities appear larger by percentage. Dynamic range and detector linearity should be checked at the actual sample load.

UV detector linearity matters too. An overloaded main peak can flatten or broaden, while a concentrated injection conceals shoulders. Evaluate at two or more loads and confirm that impurity percentages remain stable. If the profile changes with load, the reported purity is method-limited.

Photodiode-array peak-purity algorithms do not guarantee chemical homogeneity. Closely related peptides have similar UV spectra, so a coeluting deletion or epimer may pass the spectral test. LC-MS extracted spectra across the leading edge, apex, and trailing edge provide a stronger coelution check.

Common supplier-reporting errors

Some COAs label a TIC screenshot “HPLC purity.” Others show an extracted-ion trace containing only the expected mass, which will naturally look pure because unrelated impurities were excluded. Ask which signal was integrated and whether all peaks were included.

A deconvoluted mass spectrum confirms identity; it does not provide chromatographic purity. Conversely, a clean UV trace does not prove the main peak's sequence. Strong release evidence pairs selective chromatography with mass identity and, where necessary, MS/MS localization.

Do not average UV and MS percentages. If they disagree, identify the peaks causing the difference, examine response and coelution, then select the validated method appropriate to the specification. Reporting “94.8% average purity” from 98.7% UV and 90.9% TIC has no analytical meaning.

Method transfer and procurement

When transferring methods, preserve more than gradient time. Column chemistry, internal diameter, dwell volume, UV cell, additive concentration, MS source, injection solvent, and load can change the profile. Run the same reference lot at both sites and compare individual impurity recovery, not only total purity.

Store and prepare samples consistently. Oxidation, adsorption, precipitation, and autosampler degradation can create real differences between laboratories. A fresh independent preparation is often more informative than repeated injections from one aging vial.

Peptides Archive can help procurement teams interpret mismatched UV and MS purity reports and define fit-for-purpose COA requirements. This information is strictly for Research Use Only and gives no human administration, dosing, or therapeutic guidance.

Primary records and verification routes

Use the primary paper, current regulator record, or lot-linked analytical file for the claim it supports. A search result is a route to evidence, not evidence itself.